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Introduction
Caveolae, flask-shaped invaginations of the plasma membrane, 
are highly abundant in endothelial cells, and are therefore likely 
to play an important role in endothelial cell biology (Tse and 
Stan, 2010). Defining precisely how caveolae function in the 
endothelium and elsewhere has proved challenging, but phe-
notypes of mice lacking genes essential for the biogenesis of 
caveolae provide evidence that caveolae play an important role 
in the cardiovascular system. These mice have alterations in the 
permeability of continuous endothelium (Schubert et al., 2002); 
impaired angiogenesis in tumor models (Chang et al., 2009; 
Siddiqui et al., 2011); are prone to pulmonary hypertension and 
dilated cardiomyopathy (Zhao et al., 2002; Cruz et al., 2012); 
and are highly exercise intolerant (Drab et al., 2001). Humans 
with mutations in the same genes also exhibit cardiac arrhyth-
mias and pulmonary hypertension, and have enlarged blood 
vessels (Rajab et al., 2010; Austin et al., 2012). Caveolae-de-
ficient mice and humans have metabolic phenotypes consistent 
with a role for caveolae in adipocytes (Pilch and Liu, 2011) and 
muscular dystrophy (Galbiati et al., 2001a,b; Woodman et al., 
2004; Parker et al., 2007; Ardissone et al., 2013). Adipocytes 
and muscle cells are also cells where caveolae are abundant; 
hence, there is a correlation between abundance of caveolae and 
their importance for cell function.
Caveolae are formed by large complexes of caveolin and 
cavin proteins (Hill et al., 2008; Hayer et al., 2010; Ludwig et 
al., 2013; Gambin et al., 2014). Caveolins are multiply acy-
lated, embedded in the inner leaflet of the plasma membrane, 
and oligomerize to form the most membrane-proximal compo-
nent of the caveolar coat complex. Cavins are soluble proteins 
that are recruited to caveolins after biosynthetic delivery of the 
latter to the plasma membrane. Caveolin 1 and cavin 1 are both 
essential for formation of caveolae; caveolin 1−/− mice lack ca-
veolae in all cell types except for striated muscle and cavin 1−/− 
mice lack caveolae in all tissues (Drab et al., 2001; Razani et 
al., 2001; Liu et al., 2008). Caveolin 1, caveolin 2, cavin 1, and 
the additional cavins 2 and 3, can all be purified from cells as 
a single 80S caveolar coat complex after chemical cross-link-
ing (Ludwig et al., 2013).
Possible functions for endothelial caveolae include con-
trol of the endothelial nitric oxide synthase (García-Cardeña et 
al., 1996; Siddiqui et al., 2011); transport of ligands and solutes 
across the endothelial cell as transcytotic vesicles (Oh et al., 
2007; Predescu et al., 2007); mechanotransduction (Albinsson 
et al., 2008; Joshi et al., 2012); and further signaling processes 
(Parton and Simons, 2007; Collins et al., 2012).
Recent experiments in cultured cells have revived the 
idea that caveolae may have a simple mechanoprotective role 
(Dulhunty and Franzini-Armstrong, 1975; Sinha et al., 2011; 
Parton and del Pozo, 2013). In this model, caveolae act as mem-
brane convolutions that can flatten in response to forces within 
the membrane, thereby buffering such forces and reducing the 
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chance of critical membrane rupture or loss of cell–cell contact 
(Parton and del Pozo, 2013). The model is attractive because it 
provides a good explanation for the abundance of caveolae in 
some cell types. Both stretch-dependent changes in the abun-
dance of caveolae in isolated muscle fibers and pressure-depen-
dent changes in abundance of endothelial caveolar vesicles have 
been observed (Dulhunty and Franzini-Armstrong, 1975; Lee 
and Schmid-Schönbein, 1995); however, direct in vivo evidence 
that caveolae do indeed disassemble or flatten in response to 
physiological forces, and thereby protect the plasma membrane 
from disruption by mechanical stress, has been lacking. The 
situation is complicated by data suggesting that endocytosis 
of caveolae occurs in response to plasma membrane damage 
(Corrotte et al., 2013; Andrews et al., 2014; Shvets et al., 2015). 
Both endocytosis and flattening of caveolae may cause changes 
in the abundance of these structures at the plasma membrane, 
thus it is crucial to develop assays for disassembly of caveolae 
that do not rely solely on morphological criteria.
The goal of this study was to address the potential mech-
anoprotective function of caveolae in endothelial cells in vivo. 
We designed experiments to test the two key aspects of the hy-
pothesis that disassembly and flattening out of caveolae buffers 
mechanical forces within the plasma membrane (Sinha et al., 
2011). First, we asked whether disassembly of caveolae can 
be detected in intact tissue under physiological conditions. We 
used tissue culture cell experiments to characterize both bio-
chemical and electron microscopy assays for caveolar disas-
sembly and applied these assays to mice where cardiac output, 
and hence hemodynamic force on endothelial cells, is increased. 
Additional experiments rule out endocytosis as an alternative 
explanation for changes in caveolar abundance. Second, we es-
tablished an assay for acute damage to the plasma membrane 
based on membrane-impermeant nuclear dyes, validated this 
assay in cell culture experiments comparing control and caveo-
lin 1−/− cells, and applied the assay to mice under conditions of 
increased cardiac output.
Results and discussion
Biochemical assays for disassembly of 
caveolae under mechanical force
Cells of the endothelium-derived cell line bEnd5 were mechan-
ically stressed by exposure to hypo-osmotic medium, and by 
cycles of repeated stretching after growth on polydimethylsi-
loxane, a deformable substrate. We quantified the effect of these 
treatments on the abundance of morphologically defined caveo-
lae using electron microscopy of complete perimeters of multi-
ple individual cells (Fig. S1, A and B; Hansen et al., 2013). As 
predicted, both treatments rapidly and significantly reduced the 
number of morphological caveolae (Sinha et al., 2011).
If the loss of caveolae (Fig. S1) were because of disassem-
bly of caveolar coat complexes, then one would predict that this 
would release soluble caveolar proteins such as cavin 1 from the 
membrane into the cytoplasm (Hayer et al., 2010; Sinha et al., 
2011; Gambin et al., 2014). Western blotting of cytosolic frac-
tions after ultracentrifugation to pellet membranes showed that 
both hypo-osmotic medium and stretching on a deformable sub-
strate clearly caused a time-dependent increase in the cytosolic 
pool of cavin 1 (Fig. 1, A and B). Caveolin 1 remained in the 
membrane fraction, and the total amount of cavin 1 present in 
the cell did not change during the experiment (Fig. 1, C and D).
Interpretation of cytosolic accumulation of cavin 1 as di-
rect evidence for disassembly of caveolae is a central part of our 
conclusions; therefore, we performed additional experiments 
to confirm this. The cavin 1 released into the cytosol under 
hypo-osmotic conditions was present in two peaks on sucrose 
velocity gradients. The higher molecular weight peak (fraction 
8) had the same size as the basal amount of cytosolic cavin 1 de-
tected normally. Crucially, the second peak, comprising smaller 
complexes (fraction 4), was not observed under isotonic condi-
tions (Fig. 1 E). Therefore, large cavin 1–containing complexes 
disassemble under mechanical stress induced by hypotonic con-
ditions (Gambin et al., 2014).
Essentially all of the cavin and caveolin proteins present 
in caveolae can be purified as a single 80S complex after chem-
ical cross-linking (Ludwig et al., 2013). If caveolae disassem-
ble, then this complex should be lost. Incubation of cells under 
hypo-osmotic conditions for 10 min did indeed result in loss 
of the cross-linked 80S complex because caveolin 1 and cavin 
1 no longer cofractionated in high molecular weight fractions 
on sucrose gradients and instead accumulated in much smaller 
complexes (Fig. 1, F and G). This provides direct evidence for 
disassembly of the caveolar coat complex, and confirms that the 
accumulation of cavin 1 in the cytosol reported in Fig. 1 corre-
sponds to disassembly of caveolae.
It was possible that changes in the abundance of morpho-
logically defined caveolae observed by electron microscopy 
could reflect budding from the plasma membrane. Accordingly, 
we performed endocytosis assays using total surface protein bi-
otinylation to label all endosomes in bEnd5 cells (Bitsikas et al., 
2014). These experiments were performed using both hypo-os-
motic buffer and stretching after growth on a deformable sub-
strate. In hypo-osmotic conditions the extent to which caveolin 
1 colocalized with cavin 1 was markedly reduced, consistent 
with disassembly of caveolae, and under these conditions en-
docytosis was blocked (Fig. 2, A and B). Mechanical stretch-
ing by 20% with a frequency of 1 Hz reduced total endocytosis 
(Fig. 2 D), and colocalization between cavin 1 and caveolin 1 
was also reduced (Fig. 2 C). Quantification, using a pixel-mask 
approach (Shvets et al., 2015), revealed that the amount of ca-
veolin 1 in endocytic structures did not change significantly 
during mechanical stretching (Fig. 2 E). We conclude that loss 
of morphologically defined caveolae from the plasma mem-
brane is, therefore, indeed because of disassembly of caveolae.
Disassembly of endothelial caveolae in vivo
To ascertain whether the forces generated by increased blood 
flow acutely trigger disassembly of endothelial caveolae we 
used the β1-adrenoreceptor agonist dobutamine. This causes 
increased heart contractility and output and is used clinically 
to mimic effects of exercise (Marcovitz and Armstrong, 1991). 
Pulse plethysmography showed that dobutamine caused a pro-
nounced elevation of both pulse rate and pulse distension 1 min 
after i.p. injection, and both parameters reached levels seen in 
exercising mice (Fig. S2 A; Desai et al., 1997). Tissues from 
control and caveolin 1−/− mice treated for 1 min with dobuta-
mine were very rapidly dissected and snap frozen. After ho-
mogenization and cell lysis the soluble and membrane fractions 
from each tissue were isolated by centrifugation, and the pres-
ence of cavin 1 was assayed by Western blotting (see Fig. 4 A 
and Fig. S2 B). In both the heart and lung dobutamine caused an 
increase in the amount of soluble cavin 1 (Fig. 3, A and B; con-
trols in Fig. S2 B). This was not the case in abdominal muscle. 
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The data suggest that caveolae disassemble in heart and lung 
in response to dobutamine-induced increases in cardiac output.
Electron microscopy was used to confirm that morpho-
logically defined caveolae become less abundant in endothelial 
cells in response to dobutamine. The time taken for dissec-
tion and fixation of tissue and for heterogeneity in caveolar 
abundance between different sections of endothelium from 
the same tissue is a potentially confounding factor in this type 
of experiment. We focused on the heart and the lung, tissues 
that can be dissected rapidly, and where the biochemical ex-
periments reported previously suggested that an effect would 
be found. In both tissues electron microscopy of microvessels 
revealed that there are considerable stretches of plasma mem-
brane devoid of caveolae in the dobutamine-treated samples, 
although caveolae are clearly still present (Fig. 3, C and D). 
Quantification of the number of caveolae, defined as distinc-
tive omega shapes open at the luminal face of the endothelial 
cell, in complete reconstructions of microvessel perimeters 
from control and dobutamine-treated mice revealed a reduc-
tion in response to the drug (Fig.  3, E and F). Therefore, 
endothelial caveolae are indeed likely to disassemble in re-
sponse to increased cardiac output.
Caveolae prevent rupture of endothelial 
plasma membranes under physiological 
hemodynamic force
If disassembly of caveolae does protect cells from plasma mem-
brane disruption under mechanical stress, then one would predict 
that, in the absence of caveolae, cells might be more susceptible 
to acute rupture of the plasma membrane. In order assay acute 
membrane rupture we used membrane-impermeant, nucleic- 
acid-binding dyes, which will confer bright staining of the nucleus 
only when integrity of the plasma membrane is lost (Jones and 
Singer, 2001). Establishing the assay in tissue culture cells, con-
trol and caveolin 1−/− mouse embryonic fibroblasts were exposed 
to hypo-osmotic medium or mechanical stretching in the presence 
of SYT OX Green, as well as fluorescent wheat germ agglutinin 
to track the location and morphology of individual cells. After 
4 min in hypo-osmotic buffer, prominent nuclear staining was 
observed in many of the caveolin 1−/− cells (Fig. S3 A). SYT OX 
Green staining was quantified using flow cytometry (Fig. S3 B). 
Again, there was clearly significantly more staining in the cave-
olin 1−/− cells. Mechanical stretching experiments yielded essen-
tially the same result because there were significantly more SYT 
OX Green–positive nuclei in caveolin 1−/− cells when stretched 
Figure 1. Loss of plasma membrane cave-
olae under mechanical force is accompanied 
by disassembly of caveolar protein complexes. 
(A) Immunoblot analyses of cavin 1 in cytosolic 
and membrane fractions from cells lysed after 
different times in hypo-osmotic medium. Pon-
ceau staining of the relevant areas of the blot 
membrane is included to demonstrate equal 
loading. (B) Immunoblot analyses of cavin 
1 in cytosolic and membrane fractions from 
cells lysed after different times of mechanical 
stretching, the deformable substrate on which 
the cells were grown was stretched by 20%, 
repeated at 1 Hz. (C) Immunoblot analyses 
of caveolin 1 in cytosolic and membrane 
fractions from cells lysed after different times 
in hypo-osmotic medium. Ponceau staining 
of the relevant areas of the blot membrane is 
included to demonstrate equal loading. (D) Im-
munoblot analyses of cavin 1 whole cell lysates 
after different times in hypo-osmotic medium. 
(E) Cytosolic fractions from cells incubated for 
10 min in isotonic (iso) or hypotonic (hypo) 
buffer were applied to a 10–40% sucrose 
velocity gradient, and analyzed by Western 
blotting of fractions 1–12. (F) Cross-linked and 
detergent-solubilized (1% Triton X-100/1% 
octyl-glucoside) cell extracts were fractionated 
by velocity centrifugation (10–40% sucrose), 
followed by Western blotting of fractions 1–12. 
Gradients were prepared from cells incubated 
in isotonic or hypotonic buffer for 10 min. The 
high molecular weight peak of caveolin 1 
and cavin 1 corresponding to the caveolar 
coat complex (CCC) in isotonic medium is indi-
cated. (G) Quantification of the distribution of 
cavin 1 and caveolin 1 in velocity gradients as 
shown in F. Protein amounts normalized such 
that area under each curve equal to 1 was 
determined by densitometry of Western blots.
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as in previous experiments than in the controls. In this case, 
quantification was performed by confocal imaging (Fig. S3 C). 
These experiments show that staining with membrane- 
impermeant nuclear dyes can be used to assay plasma membrane 
disruption, and that caveolae do indeed protect cells from rupture 
of the plasma membrane during increased membrane tension.
Intravenous injection of FITC-albumin and propidium io-
dide (a membrane-impermeant nuclear dye analogous to SYT 
OX Green) provided a way to image blood vessels in intact 
tissue, and to label nuclei only where the plasma membrane 
is damaged. Two-photon imaging was performed in cardiac 
muscle from control and caveolin 1−/− mice, with injection of 
dobutamine to acutely increase cardiac output (Fig.  4  A and 
Fig. S2 A). Vessels in caveolin 1−/− animals were slightly less 
well-defined relative to signal from tissue, possibly reflect-
ing an increase in permeability of the endothelium (Schubert 
et al., 2002; Hansen et al., 2013). Loss of plasma membrane 
integrity in endothelial cells was indicated by nuclear stain-
ing with propidium iodide that colocalized with blood vessels 
highlighted with FITC-albumin. Although there was little or no 
membrane damage in controls, damaged endothelial cells were 
readily observed and abundant in the caveolin 1−/−, dobuta-
mine-treated animals (Fig. 4, A and B). Electron microscopy of 
cardiac muscle in control and caveolin 1−/− animals stimulated 
with dobutamine revealed that ruptured endothelial cells and 
discontinuities in the endothelial layer could be readily detected 
(Fig. 4 C). Together, these data provide direct evidence that the 
plasma membrane of caveolin 1−/− endothelial cells is less able 
to withstand the increased hemodynamic forces caused by in-
creases in cardiac output.
One of the cardiovascular phenotypes of caveolin 1−/− 
mice is that hypoxia induces heart failure (Cruz et al., 2012; 
Mathew, 2014). Because caveolin 1 is not expressed in car-
diac muscle, one would predict that this could be a result of 
endothelial cell dysfunction. Given our findings, it seemed 
likely that ruptured endothelial cells will contribute to the phe-
notype. To test this, electron microscopy was used to examine 
the ultrastructure of endothelial cells from microvessels in car-
diac muscle of the right ventricle of mice exposed to hypoxic 
conditions for 3 wk. Changes in endothelial morphology were 
strikingly apparent in the caveolin 1−/− animals (Fig. 5 A). En-
dothelial cells that appeared devoid of cytoplasmic staining, and 
had a distended membrane outline, were frequently detected 
(Fig. 5 A). Quantification of the abundance of these abnormal 
Figure 2. Mechanical force does not induce 
endocytosis of caveolae. (A) Surface biotinyla-
tion using reducible sulfo-NHS-SS-biotin was 
followed by incubation for 10 min in isotonic 
or hypotonic medium at 37°C as shown. After 
MESNa treatment to remove noninternalized 
biotin, cells were fixed and labeled with 
antibodies against caveolin 1 and cavin 1, and 
with fluorescent streptavidin. Arrows highlight 
limited presence of caveolin 1 in endocytic 
structures. Note that the streptavidin channel 
is omitted from the red/green overlay images. 
Bars, 10 µm. (B) Quantification of biotin uptake 
after surface labeling with sulfo-NHS-SS-biotin 
and MESNa treatment. Mean fluorescence in-
tensity of multiple cell regions after subtraction 
of background signal is shown. (C) Cells were 
labeled with sulfo-NHS-SS-biotin, followed by 
incubation for 10 min at 37°C, whereas the 
deformable substrate on which the cells were 
grown was stretched by 20%, repeated at 1 
Hz. After MESNa treatment to remove nonin-
ternalized biotin, cells were fixed and labeled 
with antibodies against caveolin 1 and cavin 
1, and with fluorescent streptavidin. Bars, 10 
µm. (D) Quantification of biotin uptake after 
surface labeling with sulfo-NHS-SS-biotin and 
MESNa treatment. Mean fluorescence inten-
sity of multiple cell regions after subtraction 
of background signal is shown. (E) Quantifi-
cation of the proportion of caveolin 1 pres-
ent in biotin-positive (i.e., endosomal) pixels 
after incubation as in C.
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endothelial cells confirmed that caveolae play a significant role 
in preventing cell damage during hypoxia (Fig. 5 B). We sug-
gest that endothelial cell dysfunction underlies cardiovascular 
phenotypes of caveolin 1−/− mice, and that rupture or damage 
to the plasma membrane of endothelial cells is likely to contrib-
ute to these phenotypes.
Discussion
Two different but nonexclusive mechanisms have been pro-
posed that could explain the mechanoprotective role for ca-
veolae in vivo revealed by our experiments. Caveolae can 
disassemble, and flattening of the membrane of the caveolar 
bulb would then increase the effective surface area of the cell, 
preventing buildup of excessive force within the plane of the 
membrane (Sinha et al., 2011). Additionally, caveolae may bud 
from the membrane and internalize damaged regions, leading 
to resealing (Corrotte et al., 2013). Counting of caveolae in 
the plasma membrane does not discriminate between the two 
models because both flattening and budding may decrease the 
number of surface-connected caveolae. Our in vivo experiments 
show that cavin 1 is released from the membrane to cytosolic 
fractions upon increased blood flow. Given the considerable ex 
vivo data suggesting that association of cavin 1 with caveolin 
1 at the plasma membrane is key for adoption of the charac-
teristic membrane shape of caveolae (Hill et al., 2008; Liu and 
Pilch, 2008; Hayer et al., 2010; Ludwig et al., 2013; Gambin et 
al., 2014), and our biochemical analysis of disassembly of the 
caveolar coat complex under conditions where endocytosis is 
Figure 3. Increased cardiac output causes 
caveolar disassembly in vivo. (A) Immunoblot 
analyses of cavin-1 in cytosolic fractions from 
tissues snap frozen after 1 min of treatment of 
mice with dobutamine. Samples from three 
separate animals are shown for each tissue/
treatment. Ponceau stain of the relevant West-
ern blots is also included, to confirm equal 
loading. (B) Quantification of immunoblots of 
cytosolic cavin 1 as in A. Densitometry data in 
arbitrary units were normalized such that the 
mean of the control (i.e., without dobutamine) 
for each tissue is equal to 1. Each point rep-
resents one animal; mice were 20–25 wk old. 
(C) Multiple electron micrographs to represent 
endothelium of microvessels from the heart 
of control and dobutamine-treated mice. Red 
dots indicate structures counted as caveolae 
open to the luminal side of the endothelial cell. 
Dobutamine treatment was for 1 min before 
rapid dissection and tissue fixation. Zoomed-in 
regions are shown as outlined. (D) Electron 
micrographs of microvessels from the lung of 
control and dobutamine-treated mice, as in 
C. (E) Quantification of caveolae in microvas-
cular endothelium of the heart. Dobutamine 
treatment was for 1 min. Each point represents 
one complete reconstruction of the endothe-
lium from multiple micrographs as in C; data 
are from three control and three treated mice. 
(F) As in E, but tissue is lung. RBC and WBC 
denote red and white blood cells, respectively.
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blocked in ex vivo experiments (Figs. 1 and 2), our data then 
provide strong support for the caveolae flattening model.
There is considerable evidence for endothelial cell dys-
function and cardiovascular phenotypes in mice lacking caveolin 
1; however, these phenotypes do not by themselves lend strong 
support for one specific mechanism by which caveolae act (Drab 
et al., 2001; Schubert et al., 2002; Zhao et al., 2002; Chang et 
al., 2009; Rajab et al., 2010; Siddiqui et al., 2011; Austin et al., 
2012; Cruz et al., 2012). The accumulation of damaged endo-
thelial cells under chronic conditions, such as hypoxia in our ex-
periments, could be attributable to many factors involving cell 
signaling or other processes. However, our data show that by 
using an acute perturbation (1 min of dobutamine treatment) and 
an assay, which specifically detects loss of plasma membrane in-
tegrity, that loss of caveolae leads to instantaneous rupture of the 
membrane under increased hemodynamic stress. We suggest that 
this mechanism is likely to be a contributing factor to the range of 
cardiovascular phenotypes consequent to deletion of caveolin 1.
Although disassembly of caveolae to release membrane 
convolutions, and thereby buffer mechanical force within the 
plasma membrane, is an appealingly simple mechanism by 
which caveolae may exert mechanoprotective effects, and al-
though this mechanism provides an elegant rationale for the 
extreme abundance of caveolae within endothelium, it is pos-
sible that caveolae may have further functional roles. Of note, 
mechanical insults to cells trigger phosphorylation of caveolin 
1 on Tyrosine 14, and readout of this phosphorylation by cel-
lular signaling factors may have multiple effects that remain 
to be fully determined (Volonté et al., 2001; del Pozo et al., 
2005; Joshi et al., 2012).
Repetitive membrane damage as a result of mechani-
cal force has been well studied in the context of muscle cells 
and other systems (Lammerding and Lee, 2007). Similar 
damage to endothelial cells has been less investigated; how-
ever, studies in other systems suggest multiple mechanisms 
that may allow cells to reseal damaged plasma membrane 
Figure 4. Endothelial caveolae protect cells 
from membrane damage during acute in-
creases in cardiac output in vivo. (A) Maximum 
intensity projections of z stacks of two-photon 
images (∼20 µm deep) of heart tissue from 
control and caveolin 1−/− mice injected with 
FITC-albumin (green, capillaries) and propid-
ium iodide (PI; magenta, nuclei), with and 
without injection of dobutamine. Arrows 
show PI-positive nuclei within capillaries. The 
zoomed-in view in the right-hand panel con-
firms that PI-positive nuclei are in capillaries. 
(B) Quantification of PI-positive nuclei within 
capillaries. Each point represents one image 
stack, greater than five animals were analyzed 
per condition. (C) Abnormal endothelial mor-
phology in cardiac muscle of caveolin 1−/− 
mice immediately after dobutamine treatment. 
Examples of ruptured cells and of abnormal 
gaps between cells are arrowed.
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(Lammerding and Lee, 2007; Han, 2011; Jimenez et al., 2014). 
It is probable that these or similar mechanisms act in endothe-
lial cells, thus flattening of caveolae will provide one layer 
of a complex set of processes involved in mechanoprotection. 
However, disassembly of caveolae is conceptually different 
from mechanisms for resealing damaged plasma membrane 
because it provides the cell with a method to prevent lesions 
rather than to repair them.
Materials and methods
Animal procedures
All experiments using mice were conducted under the appropriate UK 
Home Office license, and were approved by the Ethical Review Com-
mittee of the Medical Research Council, Laboratory of Molecular Bi-
ology, or of the University of Cambridge. Caveolin 1−/− mice have the 
first two exons of the CAV1 gene deleted (Razani et al., 2001). We have 
backcrossed these mice onto the C57BL/6J background for more than 
five generations (Hansen et al., 2013).
Antibodies and reagents
The following antibodies were used: rabbit anti–cavin 1 (ab48824; 
Abcam) and rabbit anti–caveolin 1 (610060; BD Biosciences). 
HRP-conjugated secondary antibodies were from DAKO and fluoro-
phore-conjugated antibodies and streptavidin were from Molecular 
Probes (Invitrogen). Further reagents include FITC-albumin (A9771; 
Sigma-Aldrich), Propidium Iodide solution (P4864; Sigma-Aldrich), 
and dobutamine (Hameln Pharmaceuticals).
Cytosol and membrane extraction—differential centrifugation
Cells were lysed in 10 mM Tris/Cl pH 7.5, 150 mM NaCl, and 0.5 mM 
EDTA without detergent by using a 25-G needle for 100 strokes. Cell 
lysates were spun at 13,500 rpm for 10 min to remove large cellular de-
bris followed by a final centrifugation step at 55,000 rpm in a benchtop 
Optima Max ultracentrifuge (Beckman Coulter) to isolate membrane 
and cytosolic fractions. For analysis of tissues from mice, the animals 
were killed by cervical dislocation. Immediately, and as rapidly as pos-
sible (within 30 s of cervical dislocation), the heart, lungs, and abdom-
inal muscle were removed in a defined order and instantly frozen in 
liquid nitrogen. Frozen tissues were ground using a pestle and mortar 
before differential centrifugation as described previously.
Sucrose velocity gradients
Chemical cross-linking was performed precisely as described (Lud-
wig et al., 2013). Either cytosolic extracts or cross-linked whole cell 
lysates in 1% (vol/vol) Triton X-100, 2% (wt/vol) octyl-glucoside 
were added atop a linear 10–40% (wt/vol) sucrose gradient prepared 
in 50  mM Tris, pH 8, 300  mM NaCl, 5  mM EDTA, and protease 
inhibitor cocktail (Roche), plus 0.2% Triton X-100 for the deter-
gent-solubilized lysates. Gradients were spun in a SW 40 Ti Rotor 
(Beckman Coulter) at 37,000 rpm for 6 h at 4°C. Twelve 1-ml frac-
tions were collected from the bottom of the gradient by tube punc-
ture (Ludwig et al., 2013).
Hypo-osmotic medium
Cells were incubated in hypo-osmotic medium containing a 1:9 ratio of 
DMEM with 10% FBS/water.
Mechanical stretching
A ShellPa mechanical cell stretcher (B-Bridge International/MetaChem 
Diagnostics) was used at a frequency of 1 cps at 20% stretch ratio within 
a 37°C incubator to stretch bEnd5 cells grown in fibronectin-coated 
(Sigma-Aldrich) chambers made from polydimethylsiloxane.
Two-photon imaging and in vivo experiments
Mice were injected intravenously with 200 µl of 25 mg/ml albumin 
conjugated to FITC (Sigma-Aldrich). Where heart stimulation was 
required, dobutamine was used at 30 µg/g intraperitoneally. For as-
sessment of damaged endothelial cells in vivo, propidium iodide was 
introduced intravenously at 2 mg/kg. Heart rates before and after 
dobutamine injections were monitored using a MouseOx Plus pulse 
oximeter (Starr Life Sciences Corp.). Heart and abdominal muscle 
were dissected for two-photon imaging of nonfixed, fresh whole-
mount tissues using a 710 NLO upright microscope (Carl Zeiss). 
A 20×, W Plan-Apochromat 20× 1.2 NA water immersion objec-
tive was used to acquire all images. Dissected tissue was immersed 
in PBS and imaged at RT.
Confocal imaging
All confocal imaging was performed using an LSM 780 inverted con-
focal microscope (Carl Zeiss) with a 63×, 1.4 NA objective, driven by 
Zen software (Carl Zeiss). Quantification of image overlap was per-
formed as described (Bitsikas et al., 2014).
Image processing
Images were handled with Adobe Photoshop and ImageJ software. 
Contrast settings were adjusted to facilitate visualization of overlaid 
pseudo-color images. All such manipulations were applied equally 
across the whole image. Where indicated, maximum intensity projec-
tions of multiple planes in z stacks were calculated using ImageJ.
Electron microscopy
Mouse tissue was dissected out and fixed in 2.5% glutaraldehyde 
2% PFA in 0.1  M Cacodylate buffer, pH 7.4.  After washing, tissue 
was post fixed in 1% osmium tetroxide, dehydrated in an ascend-
ing ethanol series followed by propylene oxide, and infiltrated and 
embedded in CY212 resin.
Figure 5. Endothelial caveolae protect cells 
from membrane damage during hypoxia in 
vivo. (A) Electron micrographs of microves-
sels from the right ventricle of heart from 
mice exposed to hypoxia for 3 wk. Magenta 
arrowhead highlights an abnormal endo-
thelial cell with loss of cytoplasmic staining. 
(B) Quantification of endothelial cells with ab-
normal morphology after 3 wk hypoxia. Each 
dot represents one animal, >20 vessels were 
examined for each animal.
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bEnd5 cells grown on MatTek glass-bottomed Petri dishes, 
subjected to hypo-osmotic medium as described, were fixed in 2.5% 
glutaraldehyde 2% PFA in 0.1 M Cacodylate buffer, as were bEnd5 
cells grown on fibronectin-coated silicon chambers after stretching. 
Cells were then processed on their growing substrate for electron mi-
croscopy as described previously but without propylene oxide. Cells 
were cut perpendicular to their growing substrate and sections of cells 
and tissue were stained with saturated aqueous uranyl acetate and 
Reynolds lead citrate and viewed at 80 kV on a Spirit or T12 TEM 
(FEI). Quantification of caveolae in endothelium was performed by 
acquiring images to trace the outline of microvessels at 6,500 magni-
fication, assembling these images into complete profiles of the vessel 
using Adobe Photoshop, and then scoring morphological caveolae blind 
to the identity of the sample.
Analysis of SYT OX Green uptake in cell lines and membrane rupture 
assay
Mouse embryonic fibroblasts were incubated in hypotonic medium for 
up to 1 h to induce membrane rupture. SYT OX Green (Life Technol-
ogies), a cell membrane-impermeant nucleic acid dye, was used at 0.5 
nM for uptake into damaged cells. Cells were trypsinized after hypo-
tonic shock and resuspended in PBS containing 10% FBS to measure 
SYT OX Green signal using an iCyt Eclipse (EC800) flow cytome-
ter (Sony). Cells were not trypsinized before flow cytometry analysis 
because trypsinization affects caveolar complex stability (del Pozo 
et al., 2005). Time-lapse imaging was performed at 1 min intervals 
in CO2-independent media.
Hypoxia
The 16-wk-old mice were placed in a hypoxic chamber (10% O2, 
21°C ± 2°C, and 55% ± 10%) for 3 wk before tissue dissection 
for electron microscopy.
Statistical analysis
All p-values are from a Mann-Whitney test. All bars in graphs represent 
the mean and SD from the mean.
Online supplemental material
Fig. S1 presents quantification of abundance of caveolae by elec-
tron microscopy in mechanically stretched cells. Fig. S2 presents 
additional data to support the assay of caveolar disassembly in 
dobutamine-treated mice shown in Fig.  3.  Fig. S3 presents assay 
of plasma membrane rupture in tissue culture cells. Online sup-
plemental material is available at http://www.jcb.org/cgi/content/
full/jcb.201504042/DC1.
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